NEW YORK CITY, NY / ACCESS Newswire / February 3, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...

Inc. (NARI) has reached a new 52-week high, with its stock price climbing to $79.7, marking a significant milestone for the ...

Just one month into 2025, a handful of stocks have already generated some massive gains. Top 2025 performers include several ...

Stryker, one of the world’s largest medtech companies, announced on January 28 that it would be selling its Spinal Implants business to ...

Argus analyst David Toung raised the firm’s price target on Stryker (SYK) to $450 from $410 and keeps a Buy rating on the shares. Argus expects ...

Learn more about whether Inari Medical, Inc. or DENTSPLY SIRONA Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Learn more about whether Bausch + Lomb Corporation or Inari Medical, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

4. Zimmer Biomet has entered into a definitive agreement to purchase Paragon 28, a medical device company focused exclusively on foot-and-ankle orthopedics.

As the name suggests, smid-cap stocks have a valuation between $200 million and $20 billion. The definition is pretty ...

Medical and surgical device makers are riding on a surge in demand as more people in the U.S., particularly older Americans, ...

Stryker reported goodwill and other impairments of $818 million related to the spine business in the fourth quarter.